Facebook Twitter LinkedIn You TUBE

Joe Landolina

CBRN, Medical & Rescue Service United States of America

Mr. Joe Landolina

Future Forces Forum Future Forces Exhibition 2016 World CBRN & Medical Congress (CEBIRAM) 2016

Chief Executive Officer
Cresilon, Inc.


Controlling a Traumatic Bleed in Seconds

87% of battlefield mortalities occur in the pre-medical treatment facility environment and 91% of potentially survivable mortalities are related to hemorrhage. Thus, uncontrolled hemorrhage is one of the leading causes of preventable deaths on the battlefield, demonstrating a clear market need for a product that can instantly stop bleeding that results from life-threatening injuries. Hemostatic devices (tourniquets, gauzes, hemostatic powders, sponges, etc.) have been developed to control and promptly stop bleeding, but existing devices often present significant drawbacks. Cresilon recognizes the potential of its hemostatic gel technology for the military, which in preliminary studies has been shown to control traumatic bleeds by achieving hemostasis in seconds. This presentation will delve into the gel technology’s properties, relevant research, and preparation for regulatory applications that are underway in our Brooklyn, New York headquarters.

Curriculum Vitae


1. Polytechnic Institute of NYU  Master of Science, Biomedical Engineering, Biomaterials Track  2011 – 2014

2. Polytechnic Institute of NYU  Bachelor of Science, Biomolecular and Chemical Engineering 

Professional Experience:

3. CEO, Co-Founder  Suneris, Inc.  September 2010 – Present  

4. Innovation Consultant Polytechnic Institute of New York University  August 2011 – December 2014

© 2010 – 2018 Future Forces FORUM Prague, All rights reserved.